Short Interest in Odyssey Health, Inc. (OTCMKTS:ODYY) Declines By 56.6%

Odyssey Health, Inc. (OTCMKTS:ODYY) was the recipient of a significant decrease in short interest in February. As of February 27th, there was short interest totaling 20,363 shares, a decrease of 56.6% from the February 12th total of 46,957 shares. Based on an average daily trading volume, of 31,438 shares, the short-interest ratio is presently 0.6 days. Based on an average daily trading volume, of 31,438 shares, the short-interest ratio is presently 0.6 days.

Odyssey Health Stock Down 0.9%

Shares of ODYY stock traded down $0.00 on Friday, reaching $0.05. 21,000 shares of the company were exchanged, compared to its average volume of 75,310. Odyssey Health has a 1 year low of $0.01 and a 1 year high of $0.13. The business has a 50-day moving average price of $0.06 and a 200 day moving average price of $0.06.

Odyssey Health Company Profile

Odyssey Health, Inc, a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc Odyssey Health, Inc was incorporated in 2014 and is based in Las Vegas, Nevada.